ctDNA-Guided Mosunetuzumab Consolidation Therapy in Older Patients With Untreated DLBCL
Latest Information Update: 13 May 2025
At a glance
- Drugs Mosunetuzumab (Primary)
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma
- Focus Pharmacodynamics
- Acronyms GOLD
Most Recent Events
- 06 May 2025 Planned initiation date changed from 1 Apr 2025 to 1 Sep 2025.
- 25 Feb 2025 New trial record